Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
about
Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazineTwo types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapyRNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway.Dormancy of metastatic melanomaA high proliferative index of recurrent melanoma is associated with worse survivalIpilimumab, a promising immunotherapy with increased overall survival in metastatic melanoma?Melanoma biology and the promise of zebrafish.Combination PPARgamma and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2.The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.Malignant melanoma: from cell kinetics to micrometastases.Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.Towards new therapeutic approaches for malignant melanoma.Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFκB activation.Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2.Functional alterations in protein kinase C beta II expression in melanoma.Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.Development of gadolinium based nanoparticles having an affinity towards melanin.In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiationTargeting angiogenesis in melanoma
P2860
Q24313552-B78A489B-3505-42F3-B192-ECC4BEEE7776Q24598856-11005EEF-ADAE-4F5D-8888-38BD056F6C72Q33494047-88216576-749A-4D52-8F33-5B40B58F44F0Q33649569-414F06B8-2885-4300-9252-DBF2109C114AQ35089965-6D803ED1-505C-4674-8955-1A38D25E013FQ35419778-E2A5806F-69D5-44C5-AD30-FA84A318345AQ37365611-1805244C-069A-473F-8394-3EC144FF2FF1Q37390008-8788C34E-5DF9-4240-BFE3-776AADE3D011Q37506648-55C6C45F-A054-41A2-8747-4F243F2447DDQ37818162-241935DE-980F-415D-8D47-9CE1DED8839DQ37886997-2D279CB6-D1C6-4BB8-A094-E135A3B25D1CQ37951743-F663AE87-E8CB-44FB-AB7E-029F386EAD1EQ38973890-0D291130-3479-4A6C-8B80-4E462584A5FCQ39516815-6BFEC68C-B0AA-422C-B6AC-E65239688B13Q39762579-ACB4C62B-BAE6-4279-A7DD-458C36B542F0Q40630464-E7435F3D-BE35-45E9-A811-D490BF085E96Q43480586-6974C87D-A847-400C-AC43-5DF5547249E5Q48756180-98A00901-F1D4-4043-B623-5AB3246EFABFQ51534151-81FF85DD-65D2-487D-89BD-19A19B969E86Q53120428-010856EF-7E6B-4936-9EBD-24CD2BE62803Q57569610-DE2435AC-D566-4866-9960-12B67A886408Q57569703-C109BD33-25F1-4279-8080-C34E56DB0A77
P2860
Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic therapy for metastati ...... isappointing to bright future?
@en
Systemic therapy for metastati ...... isappointing to bright future?
@nl
type
label
Systemic therapy for metastati ...... isappointing to bright future?
@en
Systemic therapy for metastati ...... isappointing to bright future?
@nl
prefLabel
Systemic therapy for metastati ...... isappointing to bright future?
@en
Systemic therapy for metastati ...... isappointing to bright future?
@nl
P2860
P1476
Systemic therapy for metastati ...... isappointing to bright future?
@en
P2093
Axel Hauschild
P2860
P304
P356
10.1111/J.1600-0625.2007.00673.X
P50
P577
2008-02-27T00:00:00Z